Supporting data for “THE TROJAN HORSE STRATEGY AND METALLODRUGS TO COMBAT ANTIMICROBIAL RESISTANCE” by Chenyuan Wang (9066707)

“…Notably, the co-therapy of CBS and CEF significantly increases the survival rate of mice and decreases bacterial loads in the lung in a murine acute pneumonia model. …”

Table_1_Effect of Supplementing Dairy Goat Diets With Rapeseed Oil or Sunflower Oil on Performance, Milk Composition, Milk Fatty Acid Profile, and in vitro Fermentation Kinetics.XL... by Einar Vargas-Bello-Pérez (12282713)

“…Nine Danish Landrace goats with 42 ± 5 days in milk were allocated to three treatment groups for 42 days. …”

Table_2_Effect of Supplementing Dairy Goat Diets With Rapeseed Oil or Sunflower Oil on Performance, Milk Composition, Milk Fatty Acid Profile, and in vitro Fermentation Kinetics.XL... by Einar Vargas-Bello-Pérez (12282713)

“…Nine Danish Landrace goats with 42 ± 5 days in milk were allocated to three treatment groups for 42 days. …”

The general flowchart of research methodology. by Yali Wang (332169)

“…Meanwhile, optimization investigations consisting of thermodynamic optimal design (TOD), thermodynamic and economic optimal design (TEOD), and thermodynamic, economic and environmental optimal design (TEEOD) are considered, and the performances of systems and components are compared under three optimal design scenarios. The results <a href="https://www.baidu.com/s?rsv_idx=1&tn=15007414_12_dg&wd=proves翻译&fenlei=256&usm=1&ie=utf-8&rsv_pq=f06398ff00987d3a&oq=prove&rsv_t=e735Ha0NuyAhPEhCR+rAjDMVIWE1C2sOZsORaFhddHALt4hKAB8hJ5Fu+jFo6KjaqQeiQ4M&sa=re_fy_huisou" target="_blank">prove</a> that, for S-KC, P-KC and DL-KC, the higher net power output (<i>W</i>_<i>net</i>) can be gained with decreasing condenser outlet temperature and regenerator temperature difference, and increasing evaporator temperature difference and superheat degree, the lower electricity production cost (<i>EPC</i>) can be acquired with decreasing condenser outlet temperature, evaporator temperature difference and regenerator temperature difference, while the less environment impact load (<i>EIL</i>) can be attained with decreasing condenser outlet temperature, regenerator temperature difference and basic ammonia concentration, and increasing superheat degree. …”

Working conditions for the designed KCs. by Yali Wang (332169)

“…Meanwhile, optimization investigations consisting of thermodynamic optimal design (TOD), thermodynamic and economic optimal design (TEOD), and thermodynamic, economic and environmental optimal design (TEEOD) are considered, and the performances of systems and components are compared under three optimal design scenarios. The results <a href="https://www.baidu.com/s?rsv_idx=1&tn=15007414_12_dg&wd=proves翻译&fenlei=256&usm=1&ie=utf-8&rsv_pq=f06398ff00987d3a&oq=prove&rsv_t=e735Ha0NuyAhPEhCR+rAjDMVIWE1C2sOZsORaFhddHALt4hKAB8hJ5Fu+jFo6KjaqQeiQ4M&sa=re_fy_huisou" target="_blank">prove</a> that, for S-KC, P-KC and DL-KC, the higher net power output (<i>W</i>_<i>net</i>) can be gained with decreasing condenser outlet temperature and regenerator temperature difference, and increasing evaporator temperature difference and superheat degree, the lower electricity production cost (<i>EPC</i>) can be acquired with decreasing condenser outlet temperature, evaporator temperature difference and regenerator temperature difference, while the less environment impact load (<i>EIL</i>) can be attained with decreasing condenser outlet temperature, regenerator temperature difference and basic ammonia concentration, and increasing superheat degree. …”

Life-cycle boundary of the thermodynamic cycle. by Yali Wang (332169)

“…Meanwhile, optimization investigations consisting of thermodynamic optimal design (TOD), thermodynamic and economic optimal design (TEOD), and thermodynamic, economic and environmental optimal design (TEEOD) are considered, and the performances of systems and components are compared under three optimal design scenarios. The results <a href="https://www.baidu.com/s?rsv_idx=1&tn=15007414_12_dg&wd=proves翻译&fenlei=256&usm=1&ie=utf-8&rsv_pq=f06398ff00987d3a&oq=prove&rsv_t=e735Ha0NuyAhPEhCR+rAjDMVIWE1C2sOZsORaFhddHALt4hKAB8hJ5Fu+jFo6KjaqQeiQ4M&sa=re_fy_huisou" target="_blank">prove</a> that, for S-KC, P-KC and DL-KC, the higher net power output (<i>W</i>_<i>net</i>) can be gained with decreasing condenser outlet temperature and regenerator temperature difference, and increasing evaporator temperature difference and superheat degree, the lower electricity production cost (<i>EPC</i>) can be acquired with decreasing condenser outlet temperature, evaporator temperature difference and regenerator temperature difference, while the less environment impact load (<i>EIL</i>) can be attained with decreasing condenser outlet temperature, regenerator temperature difference and basic ammonia concentration, and increasing superheat degree. …”

Image_1_Distribution and Magnitude of Regional Volumetric Lung Strain and Its Modification by PEEP in Healthy Anesthetized and Mechanically Ventilated Dogs.pdf by Joaquin Araos (11509942)

“…Respiratory system mechanics and full thoracic end-expiratory and end-inspiratory CT scan images were obtained at ZEEP. Thereafter, a PEEP of 5 cmH₂O was set and respiratory system mechanics measurements and end-expiratory and end-inspiratory images were repeated. …”

Additional file 1 of MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets by Karl Knipper (15016346)

“…This table contains the processed protein expression data and the test results of the ANOVA and Welch`s T-test investigating the difference of the proteome of neoadjuvantly treated MDM2-amplified versus non-amplified tumors. Each row contains a unique protein. Supplementary Table 5. Test results of the enrichment analyses using the pathway annotation Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway name, Gene Ontology Biological Process (GOBP) name, and Reactome name encyclopedia comparing neoadjuvantly treated MDM2-amplified tumors with non-amplified tumors. …”

Table 4_Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients.docx by Leyi Wang (408009)

“…Differences in clinical variables and lymphocyte subsets between AKI and non-AKI groups were analyzed. A predictive model was developed using LASSO and multivariate logistic regression and validated internally (5-fold cross-validation) and externally. …”

Table 2_Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients.docx by Leyi Wang (408009)

“…Differences in clinical variables and lymphocyte subsets between AKI and non-AKI groups were analyzed. A predictive model was developed using LASSO and multivariate logistic regression and validated internally (5-fold cross-validation) and externally. …”

S1 Dataset - by Marta M. Santos (17240913)

“…Twenty-four Brahman dams, pregnant from a single sire, and weighing 545 kg ± 23 kg were confined into individual pens at 174 ± 23 d of gestation, and randomly assigned into one of two dietary treatments up to 270 d of gestation: Control (CON, n = 12), consisting of a basal diet supplemented with conventional urea, where the cows were fed with diets containing 13.5 g conventional urea per kg dry matter; and PRU (PRU, n = 12), consisting of a basal diet supplemented with a urea coated to extensively prevent ruminal degradation while being intestinally digestible, where the cows were fed with diets containing 14,8 g urea protected from ruminal degradation per kg dry matter. …”

Table 6_Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients.docx by Leyi Wang (408009)

“…Differences in clinical variables and lymphocyte subsets between AKI and non-AKI groups were analyzed. A predictive model was developed using LASSO and multivariate logistic regression and validated internally (5-fold cross-validation) and externally. …”

Table 1_Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients.docx by Leyi Wang (408009)

“…Differences in clinical variables and lymphocyte subsets between AKI and non-AKI groups were analyzed. A predictive model was developed using LASSO and multivariate logistic regression and validated internally (5-fold cross-validation) and externally. …”

Table 3_Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients.docx by Leyi Wang (408009)

“…Differences in clinical variables and lymphocyte subsets between AKI and non-AKI groups were analyzed. A predictive model was developed using LASSO and multivariate logistic regression and validated internally (5-fold cross-validation) and externally. …”

Analysis of the second dimension of the rate-yield tradeoff. by Chuankai Cheng (6791417)

“…<b>Abbreviations:CS: Citrate synthase</b> (<b><i>gltA</i></b>); <b>PTAr: Phosphotransacetylase</b> (<b><i>pta</i></b> and <b><i>eutD</i></b>); <b>ac</b>: acetate excretion; <b>THD2pp</b>: NAD(P) transhydrogenase (catalyzed by the gene product of <i>pntAB</i>); <b>NADH16pp</b>: NADH dehydrogenase (<i>nuoA–N</i>); <b>NADH5</b>: NADH dehydrogenase (<i>ndh</i>; <b>GND</b>: Phosphogluconate dehydrogenase (<i>gnd</i>); <b>GAPD</b>: Glyceraldehyde-3-phosphate dehydrogenase (<i>gapA</i>); <b>ATPS</b>: ATP synthase (<i>atpA–I</i>).…”

DataSheet2_Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010–2019.PDF by Tatiana Foltanova (12000908)

“…The trend in accessibility and availability of OMPs in Slovakia between the years 2010 and 2019 was decreasing (57% OMPs in 2010 vs. 47% OMPs in 2019). …”

DataSheet1_Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010–2019.PDF by Tatiana Foltanova (12000908)

“…The trend in accessibility and availability of OMPs in Slovakia between the years 2010 and 2019 was decreasing (57% OMPs in 2010 vs. 47% OMPs in 2019). …”

AOX inhibitor supresses growth of <i>T</i>. <i>hominis</i> cells inside the RK13 host cells at early meront stages of the infection, and affects the ability to infect by the spores... by Kacper M. Sendra (14285356)

“…<b>(C)</b> To test the effects of the CCB on the parasite development after the observed loss of the AOX and mtG3PDH mitosomal fluorescent signals (Figs <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011024#ppat.1011024.g001" target="_blank">1D and 1F</a> and <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011024#ppat.1011024.s005" target="_blank">S5</a>) the drug was added 22 hours after the initiation of the infection (<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011024#ppat.1011024.s008" target="_blank">S8 Fig</a>). …”

Table_1_Impact of foliar application of syringic acid on tomato (Solanum lycopersicum L.) under heavy metal stress-insights into nutrient uptake, redox homeostasis, oxidative stres... by Jing Ma (24574)

“…Results from the present study showed that the increasing levels of Pb in the soil decreased non-significantly (P < 0.05) shoot length, root length, shoot fresh weight, root fresh weight, shoot dry weight, root dry weight, chlorophyll-a, chlorophyll-b, total chlorophyll, carotenoid content, net photosynthesis, stomatal conductance, transpiration rate, soluble sugar, reducing sugar, non-reducing sugar contents, calcium (Ca²⁺), magnesium (Mg²⁺), iron (Fe²⁺), and phosphorus (P) contents in the roots and shoots of the plants. …”

Data_Sheet_1_Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke.doc by Chuhong Tan (6292904)

“…</p><p>Results: TMAO levels showed no significant changes before and within 24 h of AIS treatment (at admission) but decreased significantly thereafter. Elevated log₂-transformed baseline TMAO levels were associated with increased risks of 90-day [odds ratio (OR), 2.62; 95% confidence interval (CI), 1.55–4.45; p < 0.001] and 12-month (OR, 3.59; 95% CI, 2.12–6.09; p < 0.001) major ischemic events, as well as 90-day (OR, 2.89; 95% CI, 1.46–5.71; p = 0.002) and 12-month (OR, 2.58; 95% CI, 1.50–4.46; p = 0.001) unfavorable functional outcomes, after adjustments for confounding factors. …”